Clinical Study Monitoring

We minimize the number of protocols assigned to each CRA, allowing them to develop protocol expertise and share lessons learned across sites, thereby promoting positive site relationships and quality data review.

Our robust monitoring activities are supported by implementing techniques such as:

  • Addressing queries remotely, prior to site visits
  • Reviewing site data trends and issues (pre-visit) to enhance productivity during site visits
  • Ongoing collaboration with data management
  • Implementing risk-based monitoring strategies when appropriate

As part of our ongoing commitment to attracting and retaining the industry’s best CRAs, we employ a dedicated in-house CRA mentor who provides new learning opportunities to our team members, continuously expanding their industry, technology, and oncology expertise.

Average Years of CRA Experience

Request a Quote

We provide ballpark costs for your clinical development planning

Ce3 has Joined Catalyst Clinical Research to create a market-leading next-generation CRO.